Denali Therapeutics IncNASDAQ:DNLI
- LAST PRICE20.4800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots18.8000/ 30
- Ask / Lots27.3000/ 10
- Open / Previous Close0.0000 / 20.4800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DNLI |
|---|---|---|
| 09:32 ET | 10129 | 20.51 |
| 09:34 ET | 1131 | 20.32 |
| 09:36 ET | 2284 | 20.41 |
| 09:38 ET | 100 | 20.34 |
| 09:39 ET | 400 | 20.33 |
| 09:41 ET | 2961 | 20.405 |
| 09:43 ET | 1528 | 20.49 |
| 09:45 ET | 2315 | 20.57 |
| 09:48 ET | 1359 | 20.55 |
| 09:50 ET | 2224 | 20.6 |
| 09:52 ET | 1184 | 20.62 |
| 09:54 ET | 2500 | 20.69 |
| 09:56 ET | 1854 | 20.75 |
| 09:57 ET | 1425 | 20.735 |
| 09:59 ET | 3712 | 20.84 |
| 10:01 ET | 3567 | 20.76 |
| 10:03 ET | 1086 | 20.725 |
| 10:06 ET | 500 | 20.52 |
| 10:08 ET | 4016 | 20.48 |
| 10:10 ET | 4368 | 20.49 |
| 10:12 ET | 683 | 20.44 |
| 10:14 ET | 2420 | 20.43 |
| 10:15 ET | 920 | 20.45 |
| 10:17 ET | 2956 | 20.45 |
| 10:19 ET | 2479 | 20.415 |
| 10:21 ET | 5233 | 20.41 |
| 10:24 ET | 2817 | 20.38 |
| 10:26 ET | 1464 | 20.38 |
| 10:28 ET | 2820 | 20.37 |
| 10:30 ET | 700 | 20.37 |
| 10:32 ET | 14459 | 20.29 |
| 10:33 ET | 2314 | 20.335 |
| 10:35 ET | 1884 | 20.33 |
| 10:37 ET | 9707 | 20.27 |
| 10:39 ET | 4813 | 20.27 |
| 10:42 ET | 2300 | 20.29 |
| 10:44 ET | 1980 | 20.27 |
| 10:46 ET | 300 | 20.28 |
| 10:48 ET | 501 | 20.27 |
| 10:50 ET | 1052 | 20.27 |
| 10:51 ET | 7855 | 20.15 |
| 10:53 ET | 1778 | 20.16 |
| 10:55 ET | 400 | 20.16 |
| 10:57 ET | 200 | 20.16 |
| 11:00 ET | 1165 | 20.17 |
| 11:02 ET | 7303 | 20.13 |
| 11:04 ET | 716 | 20.135 |
| 11:08 ET | 676 | 20.02 |
| 11:09 ET | 1421 | 20.04 |
| 11:11 ET | 100 | 20.035 |
| 11:13 ET | 775 | 20.03 |
| 11:15 ET | 2641 | 19.985 |
| 11:18 ET | 2943 | 20.05 |
| 11:20 ET | 764 | 20 |
| 11:22 ET | 200 | 19.97 |
| 11:24 ET | 2754 | 19.98 |
| 11:26 ET | 3505 | 19.96 |
| 11:27 ET | 300 | 19.94 |
| 11:29 ET | 2566 | 19.97 |
| 11:33 ET | 1131 | 19.955 |
| 11:36 ET | 1907 | 19.89 |
| 11:38 ET | 3281 | 19.915 |
| 11:42 ET | 804 | 19.93 |
| 11:44 ET | 10440 | 19.9 |
| 11:45 ET | 3360 | 19.8631 |
| 11:47 ET | 9583 | 19.87 |
| 11:49 ET | 1110 | 19.885 |
| 11:51 ET | 602 | 19.85 |
| 11:54 ET | 201 | 19.84 |
| 11:56 ET | 2080 | 19.808 |
| 11:58 ET | 701 | 19.8 |
| 12:00 ET | 100 | 19.8 |
| 12:02 ET | 6112 | 19.838 |
| 12:03 ET | 1256 | 19.84 |
| 12:05 ET | 1303 | 19.805 |
| 12:07 ET | 300 | 19.805 |
| 12:09 ET | 400 | 19.81 |
| 12:12 ET | 501 | 19.8 |
| 12:14 ET | 2135 | 19.805 |
| 12:16 ET | 968 | 19.78 |
| 12:18 ET | 1693 | 19.762 |
| 12:20 ET | 441 | 19.76 |
| 12:21 ET | 100 | 19.76 |
| 12:23 ET | 4727 | 19.7675 |
| 12:25 ET | 11327 | 19.865 |
| 12:27 ET | 738 | 19.865 |
| 12:30 ET | 2184 | 19.88 |
| 12:34 ET | 1878 | 19.84 |
| 12:36 ET | 3910 | 19.81 |
| 12:38 ET | 1988 | 19.785 |
| 12:39 ET | 200 | 19.79 |
| 12:41 ET | 2170 | 19.8 |
| 12:43 ET | 948 | 19.78 |
| 12:45 ET | 870 | 19.76 |
| 12:48 ET | 300 | 19.76 |
| 12:50 ET | 3784 | 19.77 |
| 12:52 ET | 2683 | 19.775 |
| 12:54 ET | 2103 | 19.82 |
| 12:56 ET | 522 | 19.79 |
| 12:57 ET | 100 | 19.795 |
| 12:59 ET | 490 | 19.81 |
| 01:01 ET | 1000 | 19.835 |
| 01:06 ET | 700 | 19.835 |
| 01:08 ET | 300 | 19.85 |
| 01:10 ET | 100 | 19.86 |
| 01:12 ET | 600 | 19.84 |
| 01:14 ET | 507 | 19.8325 |
| 01:15 ET | 600 | 19.82 |
| 01:17 ET | 1571 | 19.85 |
| 01:19 ET | 600 | 19.855 |
| 01:21 ET | 1981 | 19.85 |
| 01:24 ET | 927 | 19.8 |
| 01:26 ET | 700 | 19.815 |
| 01:28 ET | 1222 | 19.8 |
| 01:30 ET | 1728 | 19.775 |
| 01:32 ET | 100 | 19.78 |
| 01:33 ET | 800 | 19.83 |
| 01:35 ET | 200 | 19.86 |
| 01:37 ET | 2300 | 19.83 |
| 01:39 ET | 100 | 19.84 |
| 01:42 ET | 1098 | 19.87 |
| 01:46 ET | 400 | 19.88 |
| 01:48 ET | 253 | 19.8649 |
| 01:50 ET | 200 | 19.86 |
| 01:51 ET | 1619 | 19.88 |
| 01:53 ET | 1700 | 19.93 |
| 01:55 ET | 703 | 19.94 |
| 01:57 ET | 300 | 19.92 |
| 02:00 ET | 200 | 19.92 |
| 02:02 ET | 300 | 19.925 |
| 02:04 ET | 2542 | 20 |
| 02:06 ET | 400 | 20 |
| 02:08 ET | 2926 | 20.025 |
| 02:09 ET | 2442 | 20.05 |
| 02:11 ET | 605 | 20.03 |
| 02:13 ET | 1292 | 20.105 |
| 02:15 ET | 975 | 20.08 |
| 02:18 ET | 100 | 20.09 |
| 02:20 ET | 1376 | 20.02 |
| 02:22 ET | 200 | 20.01 |
| 02:24 ET | 840 | 19.99 |
| 02:26 ET | 2100 | 20 |
| 02:27 ET | 509 | 20.01 |
| 02:29 ET | 200 | 20.009 |
| 02:31 ET | 1200 | 19.99 |
| 02:33 ET | 699 | 19.96 |
| 02:36 ET | 300 | 19.94 |
| 02:38 ET | 900 | 19.91 |
| 02:40 ET | 2596 | 19.94 |
| 02:44 ET | 354 | 19.948 |
| 02:45 ET | 600 | 19.92 |
| 02:47 ET | 1040 | 19.88 |
| 02:49 ET | 300 | 19.88 |
| 02:51 ET | 223 | 19.87 |
| 02:54 ET | 1800 | 19.93 |
| 02:56 ET | 600 | 19.91 |
| 02:58 ET | 100 | 19.919 |
| 03:00 ET | 1000 | 19.92 |
| 03:02 ET | 534 | 19.91 |
| 03:03 ET | 200 | 19.94 |
| 03:05 ET | 100 | 19.95 |
| 03:07 ET | 5460 | 20.03 |
| 03:09 ET | 3095 | 20.04 |
| 03:12 ET | 800 | 20.07 |
| 03:14 ET | 2674 | 20.09 |
| 03:16 ET | 1907 | 20.09 |
| 03:18 ET | 200 | 20.09 |
| 03:20 ET | 1504 | 20.07 |
| 03:21 ET | 2362 | 20.045 |
| 03:23 ET | 1500 | 20.075 |
| 03:25 ET | 4941 | 20.03 |
| 03:27 ET | 9104 | 19.98 |
| 03:30 ET | 3588 | 20.02 |
| 03:32 ET | 900 | 20.04 |
| 03:34 ET | 2040 | 20.03 |
| 03:36 ET | 1514 | 20.03 |
| 03:38 ET | 8552 | 20.08 |
| 03:39 ET | 3100 | 20.119 |
| 03:41 ET | 4451 | 20.17 |
| 03:43 ET | 6452 | 20.155 |
| 03:45 ET | 3791 | 20.15 |
| 03:48 ET | 7367 | 20.18 |
| 03:50 ET | 1500 | 20.2 |
| 03:52 ET | 9087 | 20.25 |
| 03:54 ET | 8110 | 20.31 |
| 03:56 ET | 11799 | 20.24 |
| 03:57 ET | 35378 | 20.375 |
| 03:59 ET | 163251 | 20.48 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Denali Therapeutics Inc | 3.0B | -21.2x | --- |
MorphoSys AG | 2.7B | -5.5x | --- |
Amicus Therapeutics Inc | 3.0B | -20.4x | --- |
Genmab A/S | 17.4B | 21.7x | +22.71% |
Twist Bioscience Corp | 2.9B | -14.6x | --- |
Arrowhead Pharmaceuticals Inc | 3.2B | -5.9x | --- |
Company Information
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Contact Information
- Headquarters
- 161 Oyster Point BlvdSOUTH SAN FRANCISCO, CA, United States 94080-1910
- Phone
- 650-866-8548
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Vicki Sato
- President, Chief Executive Officer, Director
- Ryan Watts
- Chief Financial Officer, Chief Operating Officer, Company Secretary
- Alexander Schuth
- Chief Medical Officer
- Carole Ho
- Director
- Steven Krognes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
|---|---|
Revenue (TTM) | $295.4M |
Shares Outstanding | 142.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-0.97 |
Book Value | $7.45 |
P/E Ratio | -21.2x |
Price/Sales (TTM) | 10.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -65.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
